[ACCI-CAVIE] The Klea Holding group is taking a decisive step in its diversification strategy with the creation of Klea Pharmaceuticals. Based in Dubai, this new subsidiary’s mission is to market licensed medicines in the high-growth markets of the Middle East and Africa. Building on its previous successes in medical digitalization with Smart Salem, the group now intends to establish itself in the pharmaceutical segment with a clear ambition: to reach a turnover exceeding 50 million euros by 2032.

Klea Pharmaceuticals begins operations with a solid portfolio of 59 already registered medicines, covering both public and private markets. The business model relies on outsourced manufacturing with certified international partners (CDMOs), ensuring maximum operational agility. Following an initial rollout in the United Arab Emirates and Saudi Arabia, the subsidiary plans a strategic expansion into West Africa starting in 2027, targeting geographic areas where the need for innovative healthcare solutions is rapidly expanding.

Strategic Monitoring of Regional Healthcare Value Chains

This major breakthrough in the regional pharmaceutical sector is being monitored with particular attention by the African Center for Competitive Intelligence. As an expert in monitoring African markets, the Center analyzes the impact of agile new players like Klea on the healthcare value chain. The Center documents how these hybrid models, combining international expertise with local distribution, are redefining access to quality care on the continent.

The Center’s expertise constitutes a strategic asset for laboratories, distributors, and regulatory authorities. Through its in-depth sectoral monitoring, it enables the decryption of complex regulatory issues and competitive dynamics unique to emerging markets. It assists organizations in risk assessment and the identification of reliable local partners to secure their expansion projects in the healthcare field.

Bespoke Support for Pharmaceutical Implementation

For players wishing to establish or optimize their presence in the African pharmaceutical industry, the Center offers tailored support. It remains fully mobilized upon request to provide the strategic data and field analysis necessary to transform logistical and regulatory challenges into levers for sustainable performance.

The Editorial Team